Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Int. arch. otorhinolaryngol. (Impr.) ; 27(1): 158-165, Jan.-Mar. 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1421679

ABSTRACT

Abstract Introduction Parapharyngeal space tumors with complex anatomy and diverse histology have remained a challenging phenomenon for treating physicians. Objectives We have conducted a comprehensive web search on the PubMed, Web of Science, EMBASE, Cochrane Library, Biomedical Literature Database (CBM), and Clinicaltrials.gov databases to determine the factors that are associated with postoperative complications in parapharyngeal space tumors. Data Synthesis Two researchers reviewed all identified articles independently with a third reviewer for adjudication. Patient demographics and other clinicopathological characteristics were explored. The systematic review has identified 631 benign parapharyngeal space tumors with neurogenic and salivary tissue histology in 13 studies, with a mean age of 42.9 ± 7.76 years old and a median follow-up of 40.98 ± 19.1 months. Salivary gland (50.8%) and neurogenic (49.1%) tumors were the most common histological entities. Tumor size, location, histology, deep parotid lobe involvement, and proximity to great vessels or to the skull base were the deciding factors in selecting the surgical approach. The factors considered to select the surgical approach do not seem to have a correlation with the outcome in terms of neurological sequalae (p = 0.106). Tumors with neurogenic histology have significantly increased chances of developing neurological complication (OR 6.07; p = 0.001). Conclusion Neurologic complications are significantly associated with neurogenic benign tumors rather than surgical approach.

2.
Int Arch Otorhinolaryngol ; 27(1): e158-e165, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36714902

ABSTRACT

Introduction Parapharyngeal space tumors with complex anatomy and diverse histology have remained a challenging phenomenon for treating physicians. Objectives We have conducted a comprehensive web search on the PubMed, Web of Science, EMBASE, Cochrane Library, Biomedical Literature Database (CBM), and Clinicaltrials.gov databases to determine the factors that are associated with postoperative complications in parapharyngeal space tumors. Data Synthesis Two researchers reviewed all identified articles independently with a third reviewer for adjudication. Patient demographics and other clinicopathological characteristics were explored. The systematic review has identified 631 benign parapharyngeal space tumors with neurogenic and salivary tissue histology in 13 studies, with a mean age of 42.9 ± 7.76 years old and a median follow-up of 40.98 ± 19.1 months. Salivary gland (50.8%) and neurogenic (49.1%) tumors were the most common histological entities. Tumor size, location, histology, deep parotid lobe involvement, and proximity to great vessels or to the skull base were the deciding factors in selecting the surgical approach. The factors considered to select the surgical approach do not seem to have a correlation with the outcome in terms of neurological sequalae ( p = 0.106). Tumors with neurogenic histology have significantly increased chances of developing neurological complication (OR 6.07; p = 0.001). Conclusion Neurologic complications are significantly associated with neurogenic benign tumors rather than surgical approach.

3.
Cancers (Basel) ; 12(9)2020 Aug 27.
Article in English | MEDLINE | ID: mdl-32867094

ABSTRACT

(1) Background: Lymphoepithelial carcinoma of the hypopharynx and larynx is a rare tumor with fewer than 50 cases in the published literature. We present a literature review to discuss the clinical findings, viral or genetic associations, diagnostic challenges, histopathological findings and therapeutic aspects of the disease. (2) Methods: A comprehensive literature review was performed through MEDLINE/PubMed from 1968 to 2018. We identified 21 studies comprising 46 patients. Data on all the clinicopathological features, diagnostic modalities, treatment options and viral or genetic etiology were extracted and analyzed using SPSS. (3) Results: The mean age of presentation was 64 years (range 40-82 years) and mostly involved males. The supraglottis and pyriform sinus were the most commonly involved sub-sites, with surgery as the preferred treatment modality. The presence of the Epstein-Barr virus possibly directs a viral etiology. The incidence of cervical and distant metastasis was 54% and 21%, respectively. The median survival time was 30 months. (4) Conclusions: Lymphoepithelial carcinoma of the hypopharynx is an aggressive tumor with a strong predilection for regional and distant metastasis. Surgery, in combination with adjuvant therapy, provides promising results. Immunohistochemistry helps in differentiating LEC from other pathologies.

4.
Head Neck ; 42(5): 1057-1066, 2020 05.
Article in English | MEDLINE | ID: mdl-31922316

ABSTRACT

Sinonasal undifferentiated carcinomas (SNUCs), being an aggressive malignancy with dismal survival outcome, have given limited consideration regarding management of regional failures. A total of 12 studies, published between 1999 and 2019, met inclusion criteria. We performed a meta-analysis assessing regional (neck) relapse after elective neck treatment compared to observation in clinically node negative (N0) necks. Clinical data of 255 patients were used for meta-analysis. Among them, 83.4% of patients presented with T4 tumors and 14.1% had positive neck nodes. Elective neck treatment was applied in 49.5% of analyzed patients. Regional relapses occurred in 3.7% of patients who have undergone elective neck treatment compared to 26.4% in patients who had not. Elective neck treatment significantly reduced the risk of regional recurrence (odds ratio 0.20; 95% confidence interval 0.08-0.49; P = .0004). The meta-analysis indicates that elective neck treatment could significantly reduce the risk of regional failures in patients with SNUCs.


Subject(s)
Carcinoma, Squamous Cell , Maxillary Sinus Neoplasms , Carcinoma , Carcinoma, Squamous Cell/pathology , Elective Surgical Procedures , Humans , Neck Dissection , Neoplasm Recurrence, Local , Neoplasm Staging , Retrospective Studies
5.
PLoS One ; 13(5): e0196856, 2018.
Article in English | MEDLINE | ID: mdl-29775466

ABSTRACT

It is common in practicing orthognathic surgery to evaluate faces with retruded or protruded chins (dysgnathic faces) using photographs. Because motion may alter how the face is perceived, we investigated the perception of faces presented via photographs and videos. Two hundred naïve raters (lay persons, without maxillo facial surgery background) evaluated 12 subjects with varying chin anatomy [so-called skeletal Class I (normal chin), Class II (retruded chin), and Class III (protruded chin)]. Starting from eight traits, with Factor analysis we found a two-Factor solution, i.e. an "aesthetics associated traits cluster" and a Factor "personality traits cluster" which appeared to be uncorrelated. Internal consistency of the Factors found for photographs and videos was excellent. Generally, female raters delivered better ratings than males, but the effect sizes were small. We analyzed differences and the respective effect magnitude between photograph and video perception. For each skeletal class the aesthetics associated dimensions were rated similarly between photographs and video clips. In contrast, specific personality traits were rated differently. Differences in the class-specific personality traits seen on photographs were "smoothed" in the assessment of videos, which implies that photos enhance stereotypes commonly attributed to a retruded or protruded chin.


Subject(s)
Esthetics/psychology , Perception/physiology , Personality/physiology , Adult , Chin/physiology , Face/physiology , Female , Humans , Male , Orthognathic Surgery/methods , Orthognathic Surgical Procedures/methods , Young Adult
6.
PLoS One ; 13(2): e0191718, 2018.
Article in English | MEDLINE | ID: mdl-29390018

ABSTRACT

Typically, before and after surgical correction faces are assessed on still images by surgeons, orthodontists, the patients, and family members. We hypothesized that judgment of faces in motion and by naïve raters may closer reflect the impact on patients' real life, and the treatment impact on e.g. career chances. Therefore we assessed faces from dysgnathic patients (Class II, III and Laterognathia) on video clips. Class I faces served as anchor and controls. Each patient's face was assessed twice before and after treatment in changing sequence, by 155 naïve raters with similar age to the patients. The raters provided independent estimates on aesthetic trait pairs like ugly /beautiful, and personality trait pairs like dominant /flexible. Furthermore the perception of attractiveness, intelligence, health, the persons' erotic aura, faithfulness, and five additional items were rated. We estimated the significance of the perceived treatment related differences and the respective effect size by general linear models for repeated measures. The obtained results were comparable to our previous rating on still images. There was an overall trend, that faces in video clips are rated along common stereotypes to a lesser extent than photographs. We observed significant class differences and treatment related changes of most aesthetic traits (e.g. beauty, attractiveness), these were comparable to intelligence, erotic aura and to some extend healthy appearance. While some personality traits (e.g. faithfulness) did not differ between the classes and between baseline and after treatment, we found that the intervention significantly and effectively altered the perception of the personality trait self-confidence. The effect size was highest in Class III patients, smallest in Class II patients, and in between for patients with Laterognathia. All dysgnathic patients benefitted from orthognathic surgery. We conclude that motion can mitigate marked stereotypes but does not entirely offset the mostly negative perception of dysgnathic faces.


Subject(s)
Esthetics , Face , Orthognathic Surgical Procedures/methods , Personality , Adolescent , Adult , Female , Humans , Male , Young Adult
7.
Eur Arch Otorhinolaryngol ; 274(7): 2845-2854, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28299425

ABSTRACT

In patients with a repaired cleft palate, nasality is typically diagnosed by speech language pathologists. In addition, there are various instruments to objectively diagnose nasalance. To explore the potential of nasalance measurements after cleft palate repair by NasalView®, we correlated perceptual nasality and instrumentally measured nasalance of eight speech items and determined the relationship between sensitivity and specificity of the nasalance measures by receiver-operating characteristics (ROC) analyses and AUC (area under the curve) computation for each single test item and specific item groups. We recruited patients with a primarily repaired cleft palate receiving speech therapy during follow-up. During a single day visit, perceptive and instrumental assessments were obtained in 36 patients and analyzed. The individual perceptual nasality was assigned to one of four categories; the corresponding instrumental nasalance measures for the eight specific speech items were expressed on a metric scale (1-100). With reference to the perceptual diagnoses, we observed 3 nasal and one oral test item with high sensitivity. However, the specificity of the nasality indicating measures was rather low. The four best speech items with the highest sensitivity provided scores ranging from 96.43 to 100%, while the averaged sensitivity of all eight items was below 90%. We conclude that perceptive evaluation of nasality remains state of the art. For clinical follow-up, instrumental nasalance assessment can objectively document subtle changes by analysis of four speech items only. Further studies are warranted to determine the applicability of instrumental nasalance measures in the clinical routine, using discriminative items only.


Subject(s)
Cleft Palate/surgery , Postoperative Complications , Rhinomanometry/methods , Speech Disorders , Austria , Child , Female , Humans , Male , Postoperative Complications/diagnosis , Postoperative Complications/physiopathology , ROC Curve , Sensitivity and Specificity , Speech Disorders/diagnosis , Speech Disorders/etiology , Speech Disorders/physiopathology , Speech Production Measurement/methods
8.
PLoS One ; 12(2): e0171128, 2017.
Article in English | MEDLINE | ID: mdl-28222128

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the influence of implant diameter, length and shape on a surrogate parameter of implant survival; i.e. the implant return rate in a big data analysis. MATERIALS AND METHODS: A retrospective study was conducted and the factors influencing the success rates of 69,377 sold implants over a seven-year period were evaluated. The osseointegration program of a reseller provides reliable data of a single country. Implant loss rates were investigated using logistic regression models and regressed by implant type, diameter, and length. RESULTS: The return rate of 69,377 sold implants was 2.78% and comparable to implant loss rates in previous published prospective studies as its surrogate parameter. A total of 80% of implant returns had occurred within 157 days, and an additional 15% within 750.25 days. Diameters of 3.8 to 5.0mm showed the lowest return rates with its bottom in the 4.3mm implant whilst 6.0mm implants had significantly higher return rates. In comparison to the most sold implant length (13mm) shorter implants showed significantly higher early return rates. CONCLUSIONS: The study provides evidence that in cases of standard indications and sufficient bone, the use of screw typed dental implants with 3.8 or 4.3 diameter and 11 or 13 mm length shows the lowest implant return rates. Other implants may be selected only in specific indications.


Subject(s)
Commerce/statistics & numerical data , Dental Implants/statistics & numerical data , Dental Restoration Failure/statistics & numerical data , Adult , Age Factors , Aged , Austria , Dental Implants/economics , Dental Prosthesis Design , Dental Restoration Failure/economics , Diabetes Mellitus/epidemiology , Equipment Failure Analysis , Female , Humans , Male , Middle Aged , Retrospective Studies , Smoking/epidemiology , Time Factors
9.
Semin Musculoskelet Radiol ; 20(3): 305-314, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27741546

ABSTRACT

For patients with malignant disease taking bisphosphonates and denosumab, the incidence of medication-related osteonecrosis of the jaw (MRONJ) is up to 15% in contrast to 0.01% in patients with osteoporosis. Clinical presentation of MRONJ extends from asymptomatic exposure of bone in 94% of patients to severe cases of mandibular fractures in a minority of 4.5%. The strongest risk factors for MRONJ are invasive dental procedures and dental infections. Advances in imaging provide more preoperation information compared with panoramic radiograph. Prevention strategies are the elimination of potential risk factors leading to invasive dental procedures and maintenance of good oral hygiene prior to the administration of antiresorptive agents. Management of MRONJ depends on the underlying disease, extent of the necrosis, and the presence of contributing therapy. Conservative therapies include topical anti-infective rinses and systemic antibiotic therapy. The most important part of surgical therapy is to remove the exposed and necrotic bone. Several options for defect closure are possible from local tissue flaps to microvascular free flap procedures. The development of MRONJ in conjunction with dental implants is a severe side effect and should be avoided if potentially harmful medication has already been administered.


Subject(s)
Bone Density Conservation Agents/therapeutic use , Diphosphonates/therapeutic use , Jaw Diseases/chemically induced , Jaw Diseases/prevention & control , Osteonecrosis/chemically induced , Osteonecrosis/prevention & control , Denosumab/therapeutic use , Humans , Risk Factors
10.
J Craniomaxillofac Surg ; 43(9): 1843-8, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26346764

ABSTRACT

Bioclimatic conditions are thought to have an impact on the frequency of dental abscesses but previous studies have suffered from small patient cohorts, methodological obstacles, and restriction to a single site resulting in limited geographic and meteorological variability. The aim of the present study was to investigate the influence of environmental temperature and barometric pressure on the frequency of dental abscesses. Three maxillofacial and two dental clinics in Vienna retrospectively provided a total of 19,218 patients with dentoalveolar abscesses who were treated by intraoral incision between 1998 and 2011. Daily records from six local meteorological stations were consulted to assess daily meteorological parameters. Univariate and multivariate hurdle count regression models were fitted to estimate the effect of daily average barometric pressure and temperature on registered abscess frequencies. Temporal confounders causing variance of the observed abscess frequencies - such as weekday, business day, and month - were taken into consideration. On days of low barometric pressure a significant rise in dental abscess frequency was observed, even when adjusting for confounders. Environmental temperature, in contrast, did not show any effect. In conclusion, bioclimatic conditions affect health as low barometric pressure increases the number of patients with dental abscesses.


Subject(s)
Abscess/epidemiology , Atmospheric Pressure , Temperature , Tooth Diseases/epidemiology , Adult , Austria/epidemiology , Confounding Factors, Epidemiologic , Female , Humans , Incidence , Male , Periodontal Abscess/epidemiology , Retrospective Studies , Time Factors
11.
J Oral Maxillofac Surg ; 72(10): 1937.e1-8, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25234534

ABSTRACT

PURPOSE: Bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) is a side effect of BP therapy. Dental implants are believed to be a risk factor for developing BRONJ. In the present study, we analyzed the interval to the development of BRONJ in patients treated with BP who had received dental implants. PATIENTS AND METHODS: Patients with dental implants and established BRONJ were evaluated at the oral and maxillofacial surgery department (Medical University of Vienna). In addition, studies from 1978 to 2012 were included in a meta-analysis. Three groups were created: implantation before BP treatment, implantation after BP treatment, and implantation during BP treatment. The outcomes were evaluated using linear regression analysis. RESULTS: Patients who underwent dental implantation during (P < .001) and after (P < .001) treatment with BPs developed BRONJ more rapidly. The treatment duration with oral BPs was significantly related to the rapidity of developing BRONJ (P = .03). CONCLUSIONS: The insertion of dental implants during or after BP treatment accelerated the development of BRONJ. BRONJ occurred less frequently when the implants had been inserted before BP therapy had been started.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology , Dental Implants , Age Factors , Aged , Algorithms , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Bone Density Conservation Agents/administration & dosage , Bone Density Conservation Agents/adverse effects , Chronic Disease , Dental Implantation, Endosseous/methods , Dental Implants/adverse effects , Dental Restoration Failure , Device Removal , Diphosphonates/administration & dosage , Diphosphonates/adverse effects , Disease Progression , Female , Humans , Middle Aged , Osteoporosis, Postmenopausal/drug therapy , Retrospective Studies , Risk Factors , Smoking , Time Factors
12.
Oral Oncol ; 49(1): 66-70, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22892237

ABSTRACT

OBJECTIVES: Bisphosphonates are associated with osteonecrosis of the jaw. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) may be treated conservatively or by surgery. PATIENTS AND METHODS: 108 patients underwent surgery and 88 patients were followed for a mean period of 337 days. Age, gender, dental procedures, underlying disease, and the role of bisphosphonate treatment in the success of surgery were evaluated retrospectively. RESULTS: Surgical treatment improved the stage distribution from 19% stage I, 56% stage II and 25% stage III to 59% intact mucosa, 19% stage I and 13% stage II and 8% stage III. The improvement in the stage of disease achieved by surgery was statistically significant. Further relevant parameters that favor a positive outcome of surgery were the event triggering the outbreak of BRONJ (p=0.05) and the underlying disease (p=0.05). BRONJ in the maxilla necessitated repeat surgery significantly earlier than did BRONJ in the mandible (p=0.03). CONCLUSION: Effective surgery might improve the outcome of BRONJ, although prevention still is the most important aspect of this condition.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/surgery , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents, Local/therapeutic use , Bisphosphonate-Associated Osteonecrosis of the Jaw/classification , Bone Density Conservation Agents/adverse effects , Breast Neoplasms/drug therapy , Chlorhexidine/therapeutic use , Dental Implants , Dentures , Female , Follow-Up Studies , Humans , Hydrogen Peroxide/therapeutic use , Longitudinal Studies , Male , Mandibular Diseases/surgery , Maxillary Diseases/surgery , Multiple Myeloma/drug therapy , Neoplasms/drug therapy , Osteoporosis/drug therapy , Reoperation , Retrospective Studies , Tooth Extraction , Treatment Outcome , Wound Healing/physiology
13.
Head Neck ; 34(2): 194-200, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21400630

ABSTRACT

BACKGROUND: Bisphosphonates are known to be associated with osteonecrosis of the jaw. We assess factors underlying the success of surgical treatment in patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ). METHODS: Fifty-eight patients were investigated 6 months after having surgery. Outcome variables included the stage of disease. Factors underlying the success of surgery such as age, sex, dental procedures, underlying disease, and bisphosphonate therapy were subjected to statistical analysis. RESULTS: In all, 41 patients after surgery could be followed up. Twenty-four patients (58.5%) had an intact mucosa after surgical treatment. A statistically significant improvement was registered between preoperative and postoperative staging (p < .01). Routine dental procedures and the underlying illness influenced the outcome of surgery (p < .05). Patients with osteoporosis and multiple myeloma improved to a greater extent by surgery than those with cancer. Discontinuation of bisphosphonates was found to improve the outcome (p < .05). CONCLUSIONS: Surgery is more successful in patients with osteoporosis or multiple myeloma than in those with solid tumors. Discontinuation of bisphosphonate therapy favored the surgical outcome.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/surgery , Adult , Aged , Aged, 80 and over , Bisphosphonate-Associated Osteonecrosis of the Jaw/diagnostic imaging , Bisphosphonate-Associated Osteonecrosis of the Jaw/epidemiology , Comorbidity , Female , Humans , Male , Middle Aged , Multiple Myeloma/epidemiology , Osteoporosis/epidemiology , Radiography, Panoramic , Retrospective Studies , Treatment Outcome
14.
Wien Klin Wochenschr ; 122(21-22): 626-32, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20938747

ABSTRACT

Selective estrogen receptor modulators are compounds that act via estrogen receptors in different tissues to mediate either estrogenic or estrogen antagonistic effects in osteoporosis patients. The aim of this study was to assess the effect of the selective estrogen receptor modulator LY117018, a raloxifene analogue, on osteoclastogenesis in vitro. In primary murine bone marrow cultures osteoclasts, defined as TRAP-positive multinucleated cells, were induced by 10(-8) M 1,25-dihydroxyvitamin D(3). LY117018 at concentrations between 10(-12) M and 10(-9) M significantly reduced the number of osteoclasts. At higher concentrations no effect of LY117018 on osteoclast generation was observed. LY117018 enhanced alkaline phosphatase activity of mouse calvaria osteoblasts at a concentration of 10(-14) to 10(-7) M, but had no influence on the proliferation and transcription of RANKL and osteoprotegerin. In order to study the effect of the compound on the production of cytokines that can stimulate bone resorption, spleen cells were incubated with LY117018. Data from four-color flow cytometric analysis indicate a significantly decreased frequency of tumor necrosis factor-α positive CD8(+) cells after treatment with LY117018. These findings suggest that LY117018 can significantly inhibit the generation of osteoclasts and stimulate osteogenic differentiation in vitro. Suppression of tumor necrosis factor-α production by LY117018 may contribute to its anti-osteoclastogenic effect.


Subject(s)
Cytokines/metabolism , Osteoclasts/cytology , Osteoclasts/physiology , Pyrrolidines/administration & dosage , Selective Estrogen Receptor Modulators/administration & dosage , Thiophenes/administration & dosage , Animals , Animals, Newborn , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Mice , Osteoclasts/drug effects
15.
J Orthop Res ; 28(11): 1431-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20872578

ABSTRACT

Bone regeneration is required for fracture healing. Various procedures have been used to promote osteogenesis with bone morphogenetic proteins (BMPs). We assessed the effects of BMP-2, BMP-5, and BMP-6 in isolated and combined use on the generation of osteoblasts and osteoclasts by comparing the osteoclastic potency of each on osteoclasts of primary murine bone marrow cells. Subsequently, cells were stained for tartrate-resistant acid phosphatase, and real time PCR analysis of receptor activator of NKκB ligand and osteoprotegerin was conducted. The same combination of BMPs was used to assess their potential to enhance osteoblasts, employing a mineralization assay and real-time PCR analysis of collagen type-1, runx2, and osterix. While BMP-2 alone and the combination of BMP-2 and BMP-5 significantly enhanced osteoclastogenesis, BMP-2, BMP-5, and BMP-6 in combination did not have additional effects. However, the combined use of BMP-2, BMP-5, and BMP-6 had an additive effect on matrix mineralization and osterix expression in osteoblasts. Our study shows that the combination of BMP-2, BMP-5, and BMP-6 stimulates osteoblasts but not osteoclastogenesis. Thus, the synergistic use of various BMPs might improve effective bone regeneration in the clinical setting.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Osteoblasts/drug effects , Osteoclasts/drug effects , Animals , Bone Morphogenetic Protein 2/pharmacology , Bone Morphogenetic Protein 5/pharmacology , Bone Morphogenetic Protein 6/pharmacology , Calcification, Physiologic/drug effects , Cells, Cultured , Mice , Osteoblasts/physiology , Osteoclasts/physiology , Osteoprotegerin/genetics , RANK Ligand/genetics
16.
Article in English | MEDLINE | ID: mdl-20299248

ABSTRACT

BACKGROUND: Surgical treatment of mandibular neck fractures is frequently associated with postoperative complications. This study aims at an in-depth analysis of complication rates of surgically treated mandibular neck fractures. METHODS: All treated patients (264 male, 103 female patients, with 429 mandibular neck fractures) of the Vienna University Clinic of Maxillofacial Surgery in the period of 1995 to 2005 with at least 1 mandibular neck fracture were included. RESULTS: Of surgically treated fractures, 94.8% healed successfully after 1 open reduction, 4.4% had 2, and 0.8% had 3 open reductions. Osteosynthesis failure was 11.3% for 1 miniplate, 6.7% for 2 miniplates, and 8.5% for 1 lag screw. Of the surgically treated, 53 (21.3%) had 1 complication, 12 (4.8%) had 2, and 4 (1.6%) had 3 complications. Comparing isolated and mandibular neck fractures combined with other mandibular fractures the risk of suffering osteosynthesis failure is 3.59 in case of isolated (P = .004). CONCLUSIONS: Predominant causes of revision surgery are osteosynthesis failure, pseudarthrosis, and malposition.


Subject(s)
Fracture Fixation, Internal/adverse effects , Fractures, Malunited/etiology , Mandibular Fractures/complications , Postoperative Complications/etiology , Pseudarthrosis/etiology , Bone Plates , Bone Screws , Female , Fracture Fixation, Internal/instrumentation , Humans , Longitudinal Studies , Male , Mandibular Fractures/therapy , Treatment Outcome
17.
J Oral Maxillofac Surg ; 68(3): 647-50, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20171484

ABSTRACT

PURPOSE: Large-scale studies assessing complication rates and correlation of complications are still missing considering different fracture locations in the mandible. In the present retrospective study, complication rates of mandibular angle fractures treated by open reduction were assessed. MATERIALS AND METHODS: Three hundred twenty-two patients (259 men, 63 women) with 335 surgically treated mandibular angle fractures were included in this study. RESULTS: Fractures were caused by fights (46.6%), falls (19.2%), traffic accidents (14.6%), sports (11.9%), wisdom tooth removal (7.3%), and 0.9% other causes. Successful treatment occurred in 93.69% of fractures with 1 open reduction and in 6.31% with 2 open reductions. Of surgically treated patients, 71.47% (238) were completely free of complications. A detailed complication correlation matrix is given in the text. Ninety-five fractures treated with 1 miniplate, 170 with 2 miniplates, and 70 with other osteosynthesis concepts were compared regarding osteosynthesis failure and pseudarthrosis. CONCLUSION: Similar osteosynthesis failure rates were shown for 1 miniplate and 2 miniplates.


Subject(s)
Fracture Fixation, Internal/adverse effects , Mandibular Fractures/surgery , Adult , Bone Plates/adverse effects , Facial Nerve Injuries/etiology , Female , Fractures, Ununited/etiology , Humans , Jaw Fixation Techniques/adverse effects , Jaw Fixation Techniques/instrumentation , Male , Middle Aged , Pseudarthrosis/etiology , Retrospective Studies , Surgical Wound Infection/etiology
18.
J Bone Miner Res ; 24(1): 78-86, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18767923

ABSTRACT

Age-related osteoporosis is characterized by low bone mass, poor bone quality, and impaired osteoblastogenesis. Recently, the Hutchinson-Gilford progeria syndrome (HGPS), a disease of accelerated aging and premature osteoporosis, has been linked to mutations in the gene encoding for the nuclear lamina protein lamin A/C. Here, we tested the hypothesis that inhibition of lamin A/C in osteoblastic lineage cells impairs osteoblastogenesis and accelerates osteoclastogenesis. Lamin A/C was knocked-down with small interfering (si)RNA molecules in human bone marrow stromal cells (BMSCs) differentiating toward osteoblasts. Lamin A/C knockdown led to an inhibition of osteoblast proliferation by 26% and impaired osteoblast differentiation by 48% based on the formation of mineralized matrix. In mature osteoblasts, expression levels of runx2 and osteocalcin mRNA were decreased by lamin A/C knockdown by 44% and 78%, respectively. Furthermore, protein analysis showed that osteoblasts with diminished levels of lamin A/C also secreted less osteocalcin and expressed a lower alkaline phosphatase activity (-50%). Lamin A/C inhibition increased RANKL mRNA and protein levels, whereas osteoprotegerin (OPG) expression was decreased, resulting in an increased RANKL/OPG ratio and an enhanced ability to support osteoclastogenesis, as reflected by a 34% increase of TRACP(+) multinucleated cells. Our data indicate that lamin A/C is essential for proper osteoblastogenesis. Moreover, lack of lamin A/C favors an osteoclastogenic milieu and contributes to enhanced osteoclastogenesis.


Subject(s)
Lamin Type A/metabolism , Osteoblasts/cytology , Osteoclasts/metabolism , RANK Ligand/metabolism , Alkaline Phosphatase/metabolism , Bone Marrow Cells/cytology , Bone Resorption , Cell Differentiation , Cell Lineage , Cell Proliferation , Cells, Cultured , Humans , Microscopy, Electron, Scanning , Progeria/metabolism
19.
J Oral Maxillofac Surg ; 66(12): 2449-53, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19022122

ABSTRACT

PURPOSE: In the treatment of oral squamous cell carcinoma of the maxilla and paranasal sinuses, radical surgery and reconstruction with free flaps is accepted among many clinics. Nevertheless, the treatment protocols vary considerably. This study was performed to present our experience in the treatment of maxillary squamous cell carcinoma with surgical means alone, and to try to identify crucial prognostic factors for the patients' survival. PATIENTS AND METHODS: Thirty-six patients with primary resectable squamous cell carcinoma were included in the study. The mean age was 63 years (43-87 years) and 50% presented in advanced tumor stage (T4). Five patients (14%) already had cervical metastases. All patients were treated by radical surgery alone, and the resulting defects were closed by means of local or free flaps or the use of an obturator, respectively. RESULTS: The overall 5-year survival rate was 64%; the recurrence rate was 33%. Only patients who presented in T3 or T4 stages or had no free resection margins died during the follow-up period. Sixty-nine percent of the patients who died passed away within the first 12 months of follow-up. The 5 patients with cervical metastases received therapeutic neck dissection and showed no regional recurrence. In cases of R1 resection, adjuvant radiotherapy was applied. CONCLUSIONS: The sole surgical treatment of squamous cell carcinomas of the maxillary region led to good results, and can therefore be seen as a valuable strategy. Free resection margins and early detection of the tumor are the most important factors for success.


Subject(s)
Carcinoma, Squamous Cell/surgery , Maxillary Neoplasms/surgery , Oral Surgical Procedures/methods , Paranasal Sinus Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Disease-Free Survival , Humans , Maxilla/surgery , Maxillary Neoplasms/pathology , Middle Aged , Neoplasm Recurrence, Local , Neoplasm Staging , Palatal Obturators , Paranasal Sinus Neoplasms/pathology , Paranasal Sinuses/surgery , Prognosis , Plastic Surgery Procedures , Retrospective Studies , Risk Factors , Surgical Flaps
20.
Head Neck ; 30(9): 1224-30, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18642292

ABSTRACT

BACKGROUND: Osteonecrosis of the jaws occurs after the administration of bisphosphonates. An unequivocal treatment strategy is yet to be devised. We assess the treatment of patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ). METHODS: The investigators studied a prospective cohort of 58 patients 6 months after surgical treatment of BRONJ. Outcome variables were the status of the mucosa, the visual analog score of pain, and prosthetic rehabilitation. Preoperative staging results were compared with the postoperative outcome and statistically evaluated. RESULTS: Of 58 patients, 41 surgically treated patients could be followed up after a mean period of 189 (+/-23) days. Twenty-four (58.5%) were free of pain and had an intact mucosa. A statistically significant improvement was registered between preoperative and postoperative staging (p <.01); 11 of 12 patients who had been treated with a flap procedure for soft tissue closure had an intact mucosa. CONCLUSIONS: This is the first prospective study to report the outcome of treatment in a cohort of patients with BRONJ. Minimal resection of necrotic bone and local soft tissue closure might be a feasible treatment strategy in patients with established BRONJ.


Subject(s)
Diphosphonates/adverse effects , Jaw Diseases/chemically induced , Jaw Diseases/surgery , Osteonecrosis/chemically induced , Osteonecrosis/surgery , Administration, Oral , Adult , Age Distribution , Aged , Aged, 80 and over , Cohort Studies , Diphosphonates/administration & dosage , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Follow-Up Studies , Humans , Incidence , Injections, Intravenous , Jaw Diseases/epidemiology , Jaw Diseases/pathology , Male , Middle Aged , Osteonecrosis/epidemiology , Osteonecrosis/pathology , Osteoporosis/chemically induced , Osteoporosis/drug therapy , Osteoporosis/prevention & control , Retrospective Studies , Severity of Illness Index , Sex Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...